Normalizing glucose levels reconfigures the mammary tumor immune and metabolic microenvironment and decreases metastatic seeding

Document Details

Document Type
Pub Defense Publication
Publication Date
Oct 01, 2021
Source ID
10.1016/j.canlet.2021.05.022

Entities

People

  • Adam R. Wende
  • Brandon J. Metge
  • Chae‐myeong Ha
  • Dominique C. Hinshaw
  • Heba Allah M. Alsheikh
  • Lalita A. Shevde
  • Mateus S.v. Mota
  • Noha Sharafeldin
  • Rajeev S Samant
  • Sarah C. Kammerud
  • Tshering D Lama-Sherpa

Organizations

  • Leukemia & Lymphoma Society
  • National Cancer Institute
  • National Center for Advancing Translational Sciences
  • National Institutes of Health
  • The Breast Cancer Research Foundation
  • United States Department of Defense
  • United States Department of Veterans Affairs